Enzymatic treatment of apple juice can reduce its sugar content by 21 percent and postprandial glycaemia and venous serum insulin response by 68 percent and 47 percent, respectively, a study has shown. This further leads to a reduction of glycaemic load by 74.6 percent with no adverse gastrointestinal side effects.
Among women with severe obesity, undergoing bariatric (Roux-en-Y gastric bypass) surgery prior to conception was associated with a reduced risk of major birth defects in their infants, according to a matched cohort study conducted in Sweden.
Treatment with recombinant human parathyroid hormone (1-84) [rhPTH(1-84)] for 5 years among patients with hypoparathyroidism results in improved key biochemical parameters and a safety profile that is consistent with earlier investigations, results of the RACE study have shown.
The novel dual GIP* and GLP-1** receptor agonist tirzepatide demonstrated clinically meaningful improvements in glycaemic control and weight loss in patients with type 2 diabetes (T2D), according to data presented at EASD 2019.
An increased consumption of sugary beverages may be associated with an elevated risk of developing type 2 diabetes (T2D). Conversely, replacing sugary drinks with noncaloric drinks may reduce this risk, a large, US-based prospective study found.
A smartphone app intervention for type 2 diabetes (T2D) patients with poor medication adherence helps increase adherence awareness and reduce barriers to taking the medications as prescribed, according to the results of a feasibility study from Singapore.
The addition of the dual SGLT*1 and SGLT2 inhibitor sotagliflozin to insulin led to improvements in glycaemic control, body weight, and systolic blood pressure (SBP) in overweight/obese individuals with type 1 diabetes (T1D), according to a post hoc analysis presented at EASD 2019.